Catalyst Wire Dossier Catalyst Wire Dossier

Nubriveo

brivaracetam · UCB Pharma SA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nubriveo, covering 2026-01-27 to 2026-01-27. Get the full timeline:

Most recent: EMA Authorised: Briviact (in Italy: Nubriveo) (Brivaracetam) — UCB Pharma SA

See pricing